Trial · NCT02290444
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline on the Symbol Digit Modalities Test (SDMT) | Day 0 and Day 90 | A measure of visual processing speed and working memory. Minimum score of 0, Maximum score of 120. Higher scores indicate better performance. The difference in total correct responses on the SDMT from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Primary | Timed 25-foot Walk | Day 0 and Day 90 | An MS-specific measure of functional status walking speed. How many seconds does it take to walk 25 feet. Ceiling value of 300 seconds. |
| Primary | Change From Baseline on the Paced Auditory Serial Addition Test (PASAT) | Day 0 and Day 90 | A measure of auditory processing speed and working memory. Minimum value of 0, maximum value of 60. Higher score indicates better performance. The difference in total correct on the PASAT from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Primary | Change From Baseline on the Brief Visuospatial Memory Test-Revised (BVMT-R) | Day 0 and Day 90 | A measure of visual/spatial memory. Minimum of 0, maximum of 36. Higher score indicates better performance. The difference in total learning score on the BVMT-R from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Primary | Change From Baseline on the California Verbal Learning Test, Second Edition (CVLT-II) | Day 0 and Day 90 | A measure of auditory/verbal episodic memory. Minimum of 0, maximum of 80. Higher score indicates better performance. The difference in total learning score on the CVLT-II from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Secondary | Change From Baseline on the Expanded Disability Status Scale (EDSS). | Day 0 and Day 90 | A clinician assigned measure of disability specific to MS. Minimum of 0 (no disability), maximum of 10 (death due to MS). Higher scores indicate greater disability. The difference in total score on the EDSS from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Secondary | Change From Baseline on the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) | Day 0 and Day 90 | A self and informant rating measure of perceived cognitive problems. Minimum of 0, maximum of 60. Higher scores indicates greater self-reported neuropsychological impairment. The difference in total score on the MSNQ from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Secondary | Change From Baseline on the Beck Depression Inventory-Fast Screen (BDI-FS) | Day 0 and Day 90 | A self-report, multiple choice inventory of depression. Minimum of 0, maximum of 21. Higher score indicates higher levels of depression. The difference in total score on the BDI-FS from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Secondary | Change From Baseline on the Fatigue Severity Scale (FSS) | Day 0 and Day 90 | A self-report measure of fatigue. 1 (no fatigue) to 9 (severe fatigue). The difference in total score on FSS from Day 0 to Day 90 were analyzed to address change in this outcome. |
| Other | Incidence of Adverse Events | Up to 3 months | The number of patients reporting adverse events over the course of the study |
| Other | Change From Baseline in Concurrent Medications | Up to 3 months | Initiation or discontinuation of any medications occurring over the course of the study; monitored by clinician and study personnel. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02290444/registered